Chicago-Positive surgical margins are associated with an increased riskof cancer recurrence after radical prostatectomy, and adjuvant radiationtherapy given before recurrence may benefit patients with positive margins,according to a Memorial Sloan-Kettering Cancer Center study.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.